- Sold by Next Move Strategy Consulting
Free | 12 month subscription available.
The global Leukemia Therapeutics Market is expected to reach $29 billion by 2030, exhibiting a CAGR of 9% from 2024 to 2030. The substantial growth is attributed to the emergence of innovative treatments like bone marrow transplants and menine inhibition in cancer therapeutics. These advancements not only enhance patient outcomes but also hold the potential to positively impact the healthcare sector, driving further market expansion.